Venus Concept Inc. (VERO)
| Market Cap | 98.72M |
| Revenue (ttm) | 150.96M |
| Net Income (ttm) | -90.22M |
| Shares Out | 40.47M |
| EPS (ttm) | 2.00 |
| PE Ratio | 1.16 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 21 |
| Last Price | $2.32 |
| Previous Close | $2.40 |
| Change ($) | -0.08 |
| Change (%) | -3.33% |
| Day's Open | 2.37 |
| Day's Range | 2.22 - 2.37 |
| Day's Volume | 1,053,449 |
| 52-Week Range | 1.67 - 8.20 |
TORONTO, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary unaudi...
TORONTO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management w...
TORONTO, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (Nasdaq: VERO), a global medical aesthetic technology leader, today announced the pricing of it...
TORONTO, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it intends t...
New loan and debt exchange agreements significantly enhance balance sheet and financial condition by lowering overall cost of borrowing, reducing annual interest expense and improving future c...
TORONTO, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that the Company ...
Venus Concept, Inc. (VERO) CEO Domenic Serafino on Q3 2020 Results - Earnings Call Transcript
Venus Concept (VERO) delivered earnings and revenue surprises of 25.00% and -21.84%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the st...
Shares of Venus Concept (NASDAQ:VERO) moved higher by 3.9% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 82.35% over the past year to (...
TORONTO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for t...
TORONTO, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management w...
TORONTO, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that third quarter of f...
Venus Concept, Inc. (VERO) CEO Domenic Serafino on Q2 2020 Results - Earnings Call Transcript
Venus Concept (VERO) delivered earnings and revenue surprises of -8.33% and 2.70%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
TORONTO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for...
Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TORONTO, July 16, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary reve...
Venus Viva MD is a new skin rejuvenation solution with differentiated features that allow clinicians in the traditional medical aesthetics community to treat a wider range of skin conditions V...
TORONTO, June 26, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that the Compan...
Forget undervalued stocks, play these top-ranked stocks with rising P/E.
TORONTO, June 16, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has ent...
Venus Epileve is a new, cost-effective, laser hair removal solution designed for customers in the aesthetics market Venus Epileve is a new, cost-effective, laser hair removal solution designed...
Venus Concept Inc. (VERO) CEO Domenic Serafino on Q2 2020 Results - Earnings Call Transcript
Venus Concept (VERO) delivered earnings and revenue surprises of -14.12% and -13.54%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
TORONTO, May 14, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for ...
Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Venus Concept Inc. (VERO) CEO Domenic Serafino on Q4 2019 Results - Earnings Call Transcript
TORONTO, March 18, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it entere...
Chad A. Zaring, Appointed Chief Commercial Officer Chad A. Zaring, Appointed Chief Commercial Officer
TORONTO, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has rec...
TORONTO, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced preliminary una...
About VERO
Venus Concept operates as a medical aesthetic technology company worldwide. Its product portfolio includes aesthetic device platforms, including Venus Versa, a multi-treatment platform to address the aesthetic procedures without surgery or downtime; Venus Legacy, an advanced device that resolves challenging face and body aesthetic needs; Venus Velocity, a diode laser for hair removal; Venus Fiore, which addresses internal vaginal health restoration, labia skin tightening, and mons pubis reduction; Venus Viva, a customizable skin resurfacing dev... [Read more...]
| Industry Medical Devices | |
| CEO Domenic Serafino | Employees 525 |
| Stock Exchange NASDAQ | Ticker Symbol VERO |
Financial Performance
In 2019, Venus Concept's revenue was $110.41 million, an increase of 7.59% compared to the previous year's $102.61 million. Losses were -$40.62 million, 171.5% more than in 2018.
Analyst Forecasts
According to 5 analysts, the average rating for Venus Concept stock is "Buy." The 12-month stock price forecast is 5.50, which is an increase of 137.07% from the latest price.